MarketPeel
Insider Trading Intelligence
Pricing
…
CK

Chris Kim

LIMN
CHIEF EXECUTIVE OFFICER · LIMINATUS PHARMA, INC. · CIK 0001972385
FILING MIX · LIFETIME50%/50%
BUYS
1
SELLS
1
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jun 2026
HOLDINGS NOW
5,244,351
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Chris Kim. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
LIMN · 5,244,351 shares · as of Jul 2, 2026
01,311,0882,622,1763,933,2635,244,351SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
2026
FLOW · 1 buys / 1 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LIMN
LIMINATUS PHARMA, INC.
PURCHASE
Chief Executive Officer
3,448,926——5,244,351Jul 2, 2026Jul 14, 2026 ↗View →
LIMN
LIMINATUS PHARMA, INC.
SALE
Chief Executive Officer
4,373,603——1,795,803Jun 24, 2026Jul 6, 2026 ↗View →
Other insiders · LIMN
Loading peer insiders…
About this filer
CIK 0001972385
ROLE
Chief Executive Officer
PRIMARY
LIMN
COMPANIES
1
ACTIVE SINCE
Jun 2026
MARKETPEEL · /INSIDER/0001972385DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback